Anju Murayama

46PUBLICATIONS
34CO-AUTHORS
Clinical pharmacology and therapeuticsNot-for-profit accounting and accountabilityOther creative arts and writing not elsewhere classifiedMarketing management (incl. strategy and customer relations)International accounting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jan 29, 2026
Regulatory Disparities Between US Accelerated Approval and Japanese Authorization of Oncology Drugs: An Analysis of Evidence Quality.

Maho Iwata, Anju Murayama

|Mar 26, 2025
Cross-Sectional Analysis of Research and Non-Research Payments From the Medical Device Industry to Healthcare Professionals and Organisations in Japan in 2022.

Anju Murayama

|Feb 21, 2025
Reply by Authors.

Anju Murayama, David-Dan Nguyen, Anna-Lisa V Nguyen

|Nov 18, 2024
Pharmaceutical industry payments to healthcare professional organisations in the United Kingdom: a seven-year cross-sectional analysis of the Disclosure UK database from 2015 to 2021.

Anju Murayama, Alice Fabbri, Hannah Scholfield

|Nov 14, 2024
Industry marketing payments to physicians and prescription patterns for sacubitril/valsartan in the USA.

Anju Murayama

|Oct 25, 2024
Industry-Sponsored Research Funding to Urologists in the United States Between 2014 and 2022.

Anju Murayama, David-Dan Nguyen, Anna-Lisa V Nguyen

Pageof 8

Frequent Collaborators

15 joint publications

Akihiko Ozaki

6 joint publications

Hiroaki Saito

5 joint publications

Divya Bhandari

4 joint publications

Yuki Senoo